Screening programmes have contributed substantially to decrease in cervical, breast and colorectal cancer incidence and mortality. New frontiers in early cancer detection are upcoming. In 2024 we held a successful meeting addressing potential and challenges in the advancements, and the purpose of a new national meeting in November 2026 is to outline and discuss key elements of the most recent developments in this field, that is moving very fast.
Screening addresses people without symptoms and to save one life, a
considerable number of screening tests must be conducted. As we are facing an even more strained health care system, it is obvious that the relevance of
optimizing screening policies, guidelines and technologies has increased and likewise, it will be necessary to evaluate the future role of cancer screening in this larger context.
At previous meeting in 2024 we had international inspiration to discuss Personalized Screening, Multi-cancer Screening, AI in Cancer Screening, and Cancer Screening in a challenged Healthcare System. The messages from the meeting are summarized in a published paper. It is the intention to follow the same procedure in the upcoming 2026-meeting.
The main topics are:
• Screening in strained health systems
• Personalized screening
• Multi-cancer early detection
• Criteria for effect of screening. The outcome discussion
• Use of routine health data for identification of target groups
• Public health and health investments
Participation is limited to 65 participants and with free charge.
(A no-show fee of 1.600 DKK is charged for participants who do not show up).
Deadline for registration: September 15, 2026.
|
Programme (preliminary)
|
|
Date/time
|
Activity
|
Speaker
|
|
November 16, 2026
|
|
12:00 – 12:45
|
Registration and Lunch
|
|
12:45 – 13:00
|
Welcome and introduction to workshops
|
Berit Andersen
|
|
Chair: Lone Kjeld Petersen
|
|
13:00 – 13:30
|
Keynote:
Potential and challenges with screening programmes in strained health systems
|
Søren Brostrøm
|
|
13:40 – 13:40
|
Discussion
|
|
Chair: Stig Bojesen
|
|
13:40 – 14:20
|
Keynote: Personalized screening – experiences from WISDOM
|
Laura Esserman
|
|
14:20 – 14:40
|
Discussion
|
Mads Nielsen
|
|
14:40 – 15:00
|
Break
|
|
Chair: Elsebeth Lynge
|
|
15:00 – 15:40
|
Keynote:
Multi-cancer early detection – experiences from NHS-Galleri
|
Peter Sasieni
|
|
15:40 – 16:00
|
Discussion
|
Martin Eklund
|
|
16:00 – 16:15
|
Plenum photo
|
|
16:15 – 18:00
|
Workshops
|
|
18:30 -
|
Dinner
|
|
November 17, 2026
|
|
Chair: Stig Bojesen and Berit Andersen
|
|
09:00 – 09:30
|
Keynote:
Criteria for effect of screening. The outcome discussion
|
Harry de Koning
|
|
09:30 – 09:45
|
Discussion
|
|
09:45 – 10:15
|
Keynote:
Use of routine health data for identification of target population for cancer screening
|
Søren Brunak
|
|
10:15 – 10:30
|
Discussion
|
|
10:30 – 10:40
|
Break
|
|
Chair: Elsebeth Lynge
|
|
10:40 – 11:10
|
Keynote:
Moving health forward – public health and investments
|
Torben M. Andersen
|
|
11:10 – 11:20
|
Discussion
|
|
Chair: Stig Bojesen and Berit Andersen
|
|
11:20 – 12:00
|
Reports from workshops
|
|
12:00 – 12:10
|
Planned follow-up
|
|
12:10 – 12:45
|
Lunch
|
